The Study of Golgi Apparatus in Alzheimer’s Disease

[1]  B. Hyman,et al.  Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme , 2006, The Journal of Neuroscience.

[2]  T. Tabira,et al.  Significance of intracellular Abeta42 accumulation in Alzheimer's disease. , 2002, Frontiers in bioscience : a journal and virtual library.

[3]  W. Kamphorst,et al.  Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex, aging and Alzheimer’s disease , 2003, Neurobiology of Aging.

[4]  P. Kulinowski,et al.  2-deoxyglucose induces beta-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex. , 2004, Acta neurobiologiae experimentalis.

[5]  Xiulian Sun,et al.  BACE2, as a novel APP θ‐secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  D. Swaab,et al.  Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. , 2007, Neurobiology of aging.

[7]  T. Iwatsubo,et al.  Subcellular Compartment and Molecular Subdomain of β-Amyloid Precursor Protein Relevant to the Aβ42-promoting Effects of Alzheimer Mutant Presenilin 2* , 2001, The Journal of Biological Chemistry.

[8]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[9]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Gandy,et al.  Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway. , 2000, Journal of neurochemistry.

[11]  D. Galasko,et al.  Intracellular Aβ is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines , 2002, Neurobiology of Aging.

[12]  P. S. St George-Hyslop,et al.  Mature Glycosylation and Trafficking of Nicastrin Modulate Its Binding to Presenilins* 210 , 2002, The Journal of Biological Chemistry.

[13]  Ruth O'Hara,et al.  Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. , 2002, Journal of psychiatric research.

[14]  H. Vanderstichele,et al.  The discrepancy between presenilin subcellular localization and γ-secretase processing of amyloid precursor protein , 2001, The Journal of cell biology.

[15]  D. Swaab,et al.  Diminished neuronal metabolic activity in Alzheimer's disease , 1999, Journal of Neural Transmission.

[16]  Li-Huei Tsai,et al.  Cdk5 deregulation in the pathogenesis of Alzheimer's disease. , 2004, Trends in molecular medicine.

[17]  W. Xia,et al.  Endoproteolysis of presenilin in vitro: Inhibition by γ-secretase inhibitors , 2002 .

[18]  B. de Strooper,et al.  Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons , 1999, The Journal of cell biology.

[19]  Y. Ono,et al.  A Protein Kinase, PKN, Accumulates in Alzheimer Neurofibrillary Tangles and Associated Endoplasmic Reticulum-Derived Vesicles and Phosphorylates Tau Protein , 1998, The Journal of Neuroscience.

[20]  D. Swaab,et al.  Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of broca in Alzheimer’s disease: relation to sex and aging , 2003, Experimental Neurology.

[21]  K. Ui-Tei,et al.  Aph-1 Contributes to the Stabilization and Trafficking of the γ-Secretase Complex through Mechanisms Involving Intermolecular and Intramolecular Interactions* , 2005, Journal of Biological Chemistry.

[22]  C. Masters,et al.  Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells. , 2000, Experimental cell research.

[23]  T. Pozzan,et al.  The Golgi apparatus is an inositol 1,4,5‐trisphosphate‐sensitive Ca2+ store, with functional properties distinct from those of the endoplasmic reticulum , 1998, The EMBO journal.

[24]  Paul Greengard,et al.  Estrogen Lowers Alzheimer β-Amyloid Generation by Stimulatingtrans-Golgi Network Vesicle Biogenesis* , 2002, The Journal of Biological Chemistry.

[25]  S. Sorbi,et al.  Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. , 2006, Cell calcium.

[26]  E. V. van Someren,et al.  Therapeutic Strategies for Alzheimer Disease: Focus on Neuronal Reactivation of Metabolically Impaired Neurons , 2003, Alzheimer disease and associated disorders.

[27]  F. LaFerla,et al.  Presenilin-2 Mutations Modulate Amplitude and Kinetics of Inositol 1,4,5-Trisphosphate-mediated Calcium Signals* , 1999, The Journal of Biological Chemistry.

[28]  N. Gonatas,et al.  Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death , 2006, Journal of the Neurological Sciences.

[29]  C. Machamer.  Golgi disassembly in apoptosis: cause or effect? , 2003, Trends in cell biology.

[30]  P. Greengard,et al.  Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Gordon Whaley,et al.  The Golgi Apparatus , 1975, Cell Biology Monographs.

[32]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[33]  K. Akagawa,et al.  Syntaxin 5 interacts specifically with presenilin holoproteins and affects processing of βAPP in neuronal cells , 2005, Journal of neurochemistry.

[34]  W. Elyaman,et al.  Involvement of glycogen synthase kinase‐3β and tau phosphorylation in neuronal Golgi disassembly , 2002, Journal of neurochemistry.

[35]  M. Heneka,et al.  Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide. , 2005, The Journal of biological chemistry.

[36]  T. Tabira,et al.  Enhanced generation of intracellular Aβ42 amyloid peptide by mutation of presenilins PS1 and PS2 , 2004, The European journal of neuroscience.

[37]  Vanessa Schmidt,et al.  Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. , 2006, Biochemistry.

[38]  A. Cuello,et al.  Intracellular A-beta amyloid, A sign for worse things to come? , 2002, Molecular Neurobiology.

[39]  B. Hyman,et al.  GGA1 Acts as a Spatial Switch Altering Amyloid Precursor Protein Trafficking and Processing , 2006, The Journal of Neuroscience.

[40]  T. Saido,et al.  Effects of Neprilysin Chimeric Proteins Targeted to Subcellular Compartments on Amyloid β Peptide Clearance in Primary Neurons* , 2004, Journal of Biological Chemistry.

[41]  J. Rietdorf,et al.  Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane , 2002, The Journal of cell biology.

[42]  P. Greengard,et al.  Presenilin-1 Regulates Intracellular Trafficking and Cell Surface Delivery of β-Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.

[43]  C. Cotman,et al.  Alzheimer's Presenilin-1 Mutation Potentiates Inositol 1,4,5-Trisphosphate-Mediated Calcium Signaling in Xenopus , 1999 .

[44]  Kristina D. Micheva,et al.  Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons. , 2005, The American journal of pathology.

[45]  G. Westmeyer,et al.  A non‐amyloidogenic function of BACE‐2 in the secretory pathway , 2002, Journal of neurochemistry.

[46]  H. Qing,et al.  Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  F. Kametani,et al.  Mutant presenilin (A260V) affects Rab8 in PC12D cell , 2004, Neurochemistry International.

[48]  P. S. St George-Hyslop,et al.  APH-1 Interacts with Mature and Immature Forms of Presenilins and Nicastrin and May Play a Role in Maturation of Presenilin·Nicastrin Complexes* , 2003, The Journal of Biological Chemistry.

[49]  Ruedi Aebersold,et al.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing , 2000, Nature.

[50]  T. Hashikawa,et al.  Neurodegeneration with Tau Accumulation in a Transgenic Mouse Expressing V337M Human Tau , 2002, The Journal of Neuroscience.

[51]  K. Yanagisawa,et al.  Intracellular site of gamma-secretase cleavage for Abeta42 generation in neuro 2a cells harbouring a presenilin 1 mutation. , 2000, European journal of biochemistry.

[52]  D. Selkoe,et al.  Functional γ-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and γ-secretase substrates , 2003, Neurobiology of Disease.

[53]  J. Buxbaum,et al.  Calsenilin Enhances Apoptosis by Altering Endoplasmic Reticulum Calcium Signaling , 2002, Molecular and Cellular Neuroscience.

[54]  F. LaFerla.  Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[55]  K. Breen,et al.  The over-expression of the wild type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line , 2003, Neuroscience Letters.

[56]  R. Siman,et al.  Localization of presenilin–nicastrin complexes and γ‐secretase activity to the trans‐Golgi network , 2003, Journal of neurochemistry.

[57]  Catherine Yardin,et al.  Neurons overexpressing mutant presenilin‐1 are more sensitive to apoptosis induced by endoplasmic reticulum‐Golgi stress , 2002, Journal of neuroscience research.

[58]  T. Südhof,et al.  Regulation of APP-Dependent Transcription Complexes by Mint/X11s: Differential Functions of Mint Isoforms , 2002, The Journal of Neuroscience.

[59]  Huaxi Xu,et al.  Presenilin 1 Is Required for Maturation and Cell Surface Accumulation of Nicastrin* , 2002, The Journal of Biological Chemistry.

[60]  A. Cuello,et al.  Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human a-beta. , 2004, Journal of Alzheimer's disease : JAD.

[61]  B. de Strooper,et al.  The First Proline of PALP Motif at the C Terminus of Presenilins Is Obligatory for Stabilization, Complex Formation, and γ-Secretase Activities of Presenilins* , 2001, The Journal of Biological Chemistry.

[62]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[63]  S. Gandy,et al.  Mutant Presenilin 1 Increases the Levels of Alzheimer Amyloid β‐Peptide Aβ42 in Late Compartments of the Constitutive Secretory Pathway , 2000 .

[64]  K. Breen,et al.  Factors influencing the processing and function of the amyloid beta precursor protein--a potential therapeutic target in Alzheimer's disease? , 2000, Pharmacology & therapeutics.

[65]  M. Pákáski,et al.  Presenilin-1 and its N-terminal and C-terminal fragments are transported in the sciatic nerve of rat , 2001, Brain Research.

[66]  M. Heneka,et al.  Inhibition of Glycosphingolipid Biosynthesis Reduces Secretion of the β-Amyloid Precursor Protein and Amyloid β-Peptide*[boxs] , 2005, Journal of Biological Chemistry.

[67]  T. Bonnert,et al.  Functional Overexpression of γ-Secretase Reveals Protease-independent Trafficking Functions and a Critical Role of Lipids for Protease Activity* , 2005, Journal of Biological Chemistry.

[68]  P. Greengard,et al.  Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[70]  J. Klumperman.  Faculty Opinions recommendation of Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. , 2002 .

[71]  D. Selkoe,et al.  Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[72]  D. Selkoe,et al.  Presenilin‐1 Exists in Both Pre‐ and Post‐Golgi Compartments and Recycles Via COPI‐Coated Membranes , 2003, Traffic.

[73]  J. Buxbaum,et al.  Subcellular localization of presenilin 2 endoproteolytic C-terminal fragments. , 2001, Brain research. Molecular brain research.

[74]  G. Pasinetti,et al.  Expression of tau reduces secretion of Aβ without altering the amyloid precursor protein content in CHOsw cells , 2005, FEBS letters.

[75]  P. Greengard,et al.  Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling , 2001, The Journal of Neuroscience.

[76]  S. Gandy,et al.  Alzheimer disease: presenilin springs a leak , 2006, Nature Medicine.

[77]  R. Doms,et al.  β-Secretase Processing in the Trans-Golgi Network Preferentially Generates Truncated Amyloid Species That Accumulate in Alzheimer's Disease Brain* , 2002, The Journal of Biological Chemistry.

[78]  C. Hock,et al.  Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. , 2000, Archives of neurology.

[79]  P. Greengard,et al.  The Transmembrane Domain of the Alzheimer's β-Secretase (BACE1) Determines Its Late Golgi Localization and Access to β-Amyloid Precursor Protein (APP) Substrate* , 2001, The Journal of Biological Chemistry.

[80]  D. Swaab,et al.  Sex differences in estrogen receptor α and β expression in vasopressin neurons of the supraoptic nucleus in elderly and Alzheimer’s disease patients: no relationship with cytoskeletal alterations , 2002, Brain Research.

[81]  K. Akagawa,et al.  Syntaxin 5 interacts with presenilin holoproteins, but not with their N- or C-terminal fragments, and affects beta-amyloid peptide production. , 2004, The Biochemical journal.

[82]  P. Greengard,et al.  The transmembrane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. , 2001, The Journal of biological chemistry.

[83]  M. Fiedorowicz,et al.  Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin. , 2004, Acta neurobiologiae experimentalis.

[84]  D. Selkoe,et al.  Presenilin‐1‐mediated Retention of APP Derivatives in Early Biosynthetic Compartments , 2006, Traffic.

[85]  R. Verwer,et al.  Increased Metabolic Activity in Nucleus Basalis of Meynert Neurons in Elderly Individuals With Mild Cognitive Impairment as Indicated by the Size of the Golgi Apparatus , 2006, Journal of neuropathology and experimental neurology.

[86]  P. Greengard,et al.  Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[87]  S. Hoyer.  Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. , 2004, Advances in experimental medicine and biology.

[88]  C. Austin,et al.  Presenilin-Dependent Gamma-Secretase Activity Modulates Neurite Outgrowth , 2002, Neurobiology of Disease.

[89]  R. Ravid,et al.  Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging and Alzheimer’s disease , 2003, Brain Research.

[90]  G. Gouras,et al.  Alzheimer beta-amyloid peptides: normal and abnormal localization. , 2002, Histology and histopathology.

[91]  D. Beju,et al.  The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. , 2005, Biochemical and biophysical research communications.

[92]  Masahiro Shibata,et al.  Insights into the Phosphoregulation of β‐Secretase Sorting Signal by the VHS Domain of GGA1 , 2004, Traffic.

[93]  R. Verwer,et al.  ApoE ϵ4 Genotype Is Accompanied by Lower Metabolic Activity in Nucleus Basalis of Meynert Neurons in Alzheimer Patients and Controls as Indicated by the Size of the Golgi Apparatus , 2004, Journal of neuropathology and experimental neurology.

[94]  D. Selkoe,et al.  Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. , 2003, Neurobiology of disease.

[95]  R. Doms,et al.  Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. , 2002, The Journal of biological chemistry.

[96]  K. Yanagisawa,et al.  Intracellular site of γ‐secretase cleavage for Aβ42 generation in Neuro 2a cells harbouring a presenilin 1 mutation , 2000 .

[97]  B. de Strooper,et al.  γ-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation , 2003, Journal of Cell Science.

[98]  M. Bornens,et al.  The Golgi apparatus at the cell centre. , 2003, Current opinion in cell biology.

[99]  N. Gonatas.  The Golgi apparatus in disease , 1997 .